Targeting MRP3 in Pancreatic Cancer In Vitro

Targeting MRP3 in Pancreatic Cancer In Vitro

Pancreatic cancer is currently one of the most aggressive and resistant cancers. The incidences rates of pancreatic cancer are comparatively low. However, the death rates of pancreatic cancer are within the top 10 of all cancers worldwide. The five-year survival rate is currently 5%, meaning that 95...

Full description

Bibliographic Details
Main Author: Dantzic, Daniel Deveraux Estevan (Author)
Other Authors: Li, Yan (Contributor), Merien, Fabrice (Contributor), Liu, Dong-Xu (Contributor)
Format: Others
Published: Auckland University of Technology, 2020-06-16T00:33:28Z.
Subjects:
Cancer
Pancreatic cancer
MRP3
ABCC3
In vitro
Molecular biology
ABC Transporters
Bioinformatics
CRISPR Cas9
Drug resistance
Multidrug resistance
Suramin
Curcumin
EF24
Gemcitabine
Methotrexate
Benzbromarone
CMFDA
Flow cytometry
Transport protein
Inhibition
Drug study
Thesis
Online Access:Get fulltext

Internet

Get fulltext

Similar Items